VEROSPIRON

Medicinal product

(Invented) name

VEROSPIRON

Active substance (s)

Spironolaktonas

Strength

25 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C03DA01, Spironolactone

Marketing authorisation holder

Gedeon Richter Plc, Vengrija

Date of authorisation

1994-06-22

Date of renewal

2008-02-22

Documents

1032 Pakuotės lapelis tab 2022 02 24.docx

1032 VEROSPIRON tab PCS PL 2022 02 24.docx

Stage

Išregistruotas

Controlled?

No

Controlled substance type

Legal basis

10a

Procedure number

Marketing authorisation procedure

Nacionalinė procedūra

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Spironolaktonas	25 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
7317	1966	1001966	lizdinė plokštelė	N20		Receptinis	LT/1/94/1032/001	Netiekiama	-	-	No	-	-	Download
56933	71040	1071040	lizdinė plokštelė	N60		Receptinis	LT/1/94/1032/004	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2023-01-31	Išregistruotas
2008-02-22	Perregistruotas
1994-06-22	Registruotas